Nasus PharmaNSRX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 10 institutions reported holding Nasus Pharma Ltd. (NSRX) in their 13F filings, up 1 from Q1 2026. 4 opened new positions and 3 sold out. The largest holders were Balyasny Asset Management L.P. ($3.1M), Cable Car Capital, LP ($2.2M) and Velan Capital Investment Management LP ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Nasus Pharma Ltd.
- CUSIP
- M7071P109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $178K |
| Exits | 3 | $195K |
All 13F filers, Q1 2026 → Q2 2026: 64,931 shares bought and 88,794 shares sold, net −23,863 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Balyasny Asset Management L.P. | 0.01% | No change | 898,473 | $3.1M |
| Cable Car Capital, LP | 0.05% | Add +2.3% | 616,081 | $2.2M |
| Velan Capital Investment Management LP | 0.77% | No change | 359,390 | $1.3M |
| Hudson Bay Capital Management LP | 0.00% | No change | 134,771 | $472K |
| Bleichroeder LP | 0.06% | No change | 89,848 | $314K |
| Citadel Advisors | 0.00% | New | 22,004 | $77K |
| XTX Topco Ltd | 0.00% | New | 16,640 | $58K |
| Renaissance Technologies | 0.00% | New | 12,200 | $43K |
| Morgan Stanley | 0.00% | Reduce -50.0% | 1,000 | $4K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 4 | $14 |
"% of holder's portfolio" is NSRX's weight in each manager's 13F, not the share of Nasus Pharma Ltd. the manager owns.